186 related articles for article (PubMed ID: 32039804)
1. Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein.
Hu JL; Zhang YJ; Zhang JM; Zhu S; Li DM; Yin YF; Su J; Chan Y; He J; Cao YJ; Zhu BS
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):73-78. PubMed ID: 32039804
[TBL] [Abstract][Full Text] [Related]
2. First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Hu J; Zhang J; He G; Zhu S; Tang X; Su J; Li Q; Kong Y; Zhu B
BMC Pregnancy Childbirth; 2020 Feb; 20(1):104. PubMed ID: 32050927
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening.
Bartkute K; Balsyte D; Wisser J; Kurmanavicius J
J Perinat Med; 2017 Oct; 45(7):817-820. PubMed ID: 27771626
[TBL] [Abstract][Full Text] [Related]
5. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
7. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Kuo PL; Lin CC; Lin YH; Guo HR
J Formos Med Assoc; 2003 May; 102(5):319-25. PubMed ID: 12874670
[TBL] [Abstract][Full Text] [Related]
8. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
Yefet E; Kuzmin O; Schwartz N; Basson F; Nachum Z
Fetal Diagn Ther; 2017; 42(4):285-293. PubMed ID: 28395283
[TBL] [Abstract][Full Text] [Related]
11. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A
Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
13. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
14. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
15. Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis.
Yuan W; Chen L; Bernal AL
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):57-64. PubMed ID: 19457604
[TBL] [Abstract][Full Text] [Related]
16. Mid-trimester maternal serum markers in predicting adverse pregnancy outcome.
Androutsopoulos G; Gkogkos P; Papadopoulos V; Adonakis G; Tsapanos V; Vassilakos P; Panayiotakis G; Decavalas G
Clin Exp Obstet Gynecol; 2009; 36(4):237-40. PubMed ID: 20101856
[TBL] [Abstract][Full Text] [Related]
17. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
Chen Y; Dai X; Wu B; Jiang C; Yin Y
BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
[TBL] [Abstract][Full Text] [Related]
18. Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
Nunthapiwat S; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Gynecol Obstet Invest; 2019; 84(4):326-333. PubMed ID: 30602167
[TBL] [Abstract][Full Text] [Related]
19. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
Lepage N; Chitayat D; Kingdom J; Huang T
Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
[TBL] [Abstract][Full Text] [Related]
20. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
